Attached files

file filename
EX-10.3 - EXHIBIT 10.3 1ST AMENDMENT TO CONSULTANCY AGREEMENT - VOLITIONRX LTDf10q033116_ex10z3.htm
EX-10.2 - EXHIBIT 10.2 CONSULTANCY AGREEMENT - VOLITIONRX LTDf10q033116_ex10z2.htm
EX-31.1 - EXHIBIT 31.1 SECTION 302 CERTIFICATION - VOLITIONRX LTDf10q033116_ex31z1.htm
10-Q - FORM 10-Q QUARTERLY REPORT - VOLITIONRX LTDf10q033116_10q.htm
EX-31.2 - EXHIBIT 31.2 SECTION 302 CERTIFICATION - VOLITIONRX LTDf10q033116_ex31z2.htm
EX-10.1 - EXHIBIT 10.1 1ST AMENDMENT TO CHAIRMAN'S AGREEMENT - VOLITIONRX LTDf10q033116_ex10z1.htm
EX-10.4 - EXHIBIT 10.4 FRENCH SALE AGREEMENT - VOLITIONRX LTDf10q033116_ex10z4.htm



 

Exhibit 32.1

 

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

The following certifications are being furnished solely to accompany the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2016 (the “Report”) pursuant to U.S.C. Section 1350, and pursuant to SEC Release No. 33-8238 are being “furnished” to the SEC rather than “filed” either as part of the Report or as a separate disclosure statement, and are not to be incorporated by reference into the Report or any other filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

Certification of the Principal Executive Officer 


I, Cameron Reynolds, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of VolitionRx Limited as of, and for, the periods presented in such Report.

 

Date:

May 13, 2016

By: /s/ Cameron Reynolds

 

 

Cameron Reynolds

President and Principal Executive Officer

 

Certification of the Principal Financial Officer 


I, David Kratochvil, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of VolitionRx Limited as of, and for, the periods presented in such Report.

 

Date:

May 13, 2016

By: /s/ David Kratochvil

 

 

David Kratochvil

Chief Financial Officer and Principal Financial and Accounting Officer